EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tissue markers may predict treatment response to antitumor necrosis factor‐α agents in children with Crohn's disease

Alexander Krauthammer iD, Tal Cozacov, Sophia Fried, Adi Har-Zahav, Raanan Shamir, Amit Assa, Orith Waisbourd-Zinman

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Alexander Krauthammer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Schneider Children's Medical Center of Israel, Institute of Gastroenterology, Nutrition and Liver Diseases, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Crohn Disease, Antineoplastic Agents. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Israeli Society of Pediatric Gastroenterology and Nutrition (ISPGHAN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Patients with moderate‐severe Crohn's disease (CD) who are treated with antitumor necrosis factor alpha (TNF‐α) agents may be subjected to primary nonresponse or partial response. We aimed to identify tissue markers that may predict response to these agents.

Methods

Pediatric patients (6–18 years) with either ileal or ileo‐colonic CD who were treated with anti‐TNF‐α were stratified into three different groups based on their overall response to therapy at the end of induction including clinical and laboratory parameters (group 1—full responders [FR], group 2—partial responders [PR], group 3—nonresponders [NR]). Seven tissue markers (fibronectin, interleukin [IL]‐23R, IL‐23, TNF‐α, collagen‐III, IL‐13R, and hypoxia‐inducible factors [HIF]‐1α) were evaluated. Immunofluorescence (IF) analyses were performed on biopsies from the terminal ileum, which were retrieved up to 6 months before treatment initiation.

Results

Twenty‐six CD patients (16 [61.5%] males; age 13.9 ± 2.9 years), including 8 (30.8%) with ileal disease and 18 (69.2%) with ileo‐colonic disease, were enrolled. Terminal ileum biopsies from nine patients from group 1, nine from group 2, and eight from group 3 were evaluated. Three antibodies were found to be significantly different between NR and FR groups; Collagen III and fibronectin stains were significantly more prominent in NR patients, while TNF‐α stain was significantly more pronounced in FR, p < 0.05 for each. PR could not have been predicted with neither of markers.

Conclusions

Decreased tissue IF intensity of fibronectin and collagen III and increased intensity of TNF‐α may predict response to anti‐TNF‐α treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseAntineoplastic AgentsMaleHumansChildAdolescentFemaleTumor Necrosis Factor-alphaInfliximabFibronectinsTumor Necrosis Factor InhibitorsNecrosisCollagenTreatment Outcome

Stichwörter der Autor:innen

immunofluorescenceinflammatory bowel diseasepersonalized medicineprecisionremission

Substanzen

Tumor Necrosis Factor-alphaInfliximabFibronectinsTumor Necrosis Factor InhibitorsAntineoplastic AgentsCollagen

Autor:innen und Institutionen

  • Schneider Children's Medical Center of Israel, Institute of Gastroenterology, Nutrition and Liver Diseases, Petah Tikva, Israel.
  • Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Felsenstein Medical Research Center, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, The Hebrew University, Jerusalem, Israel.

ORCID-Profile: Alexander Krauthammer

Förderung

  • Israeli Society of Pediatric Gastroenterology and Nutrition (ISPGHAN)

Zitieren

APA

Krauthammer, A., Cozacov, T., Fried, S., Har-Zahav, A., Shamir, R., Assa, A., & Waisbourd-Zinman, O. (2024). Tissue markers may predict treatment response to antitumor necrosis factor‐α agents in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12146

Vancouver

Krauthammer A, Cozacov T, Fried S, Har-Zahav A, Shamir R, Assa A, et al. Tissue markers may predict treatment response to antitumor necrosis factor‐α agents in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12146

BibTeX
@article{Krauthammer2024,
  author = {Krauthammer, Alexander and Cozacov, Tal and Fried, Sophia and Har-Zahav, Adi and Shamir, Raanan and Assa, Amit and Waisbourd-Zinman, Orith},
  title = {Tissue markers may predict treatment response to antitumor necrosis factor‐α agents in children with Crohn's disease},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12146}
}
Kostenlos starten →